Drug Discovery - Tropical Diseases Conference 2011

  • Conference Call
  • Global Challenges for New Drug Discovery Against Tropical Diseases

    The tropical parasitic diseases are responsible for staggering morbidity and millions of deaths every year, especially in the tropical regions of the word. Although incidences of these diseases are mostly centered in tropical regions the socioeconomic and public health impacts of tropical parasitic diseases are global. Emergence and spread of drug-resistant and more virulent strains of the parasites have further intensified the problem. Despite of the heavy burden on humanity the tropical parasitic diseases have been mostly ignored in relation to advances in modern drug discovery and only few new antipatasitic drugs have been developed during last several years. Improved global attention with increasing funding opportunities through public and non-profit organizations as well as emergence of public-private partnerships for development of strategies to monitor, treat, control and eliminate neglected tropical parasitic diseases have generated.

    This conference shall focus on multidisciplinary efforts directed against control, treatments and elimination of neglected parasitic diseases. Scientific sessions will be organized specifically (but not limited to) focusing on:

    1. Social, economic and community-based programs in neglected tropical infectious diseases

    2. Drug Resistance: Monitoring, treatment and containment programs

    3. Translational research: from bench-side to bed-side

    4. Enriching the drug-discovery pipeline- Structural biology/ Molecular biology and therapeutics; Chemical biology/ Medicinal chemistry and therapeutics and In vitro/in vivo pharmacology and efficacy models.

    Plenary Speakers

    • Larry Walker (University of Mississippi)
    • Peter Myler (Seattle Biomedical Research Institute)
     
    • Ronald Quinn (Eskitis Institute, Griffith University)
    • Timothy N.C.  Wells (Medicines for Malaria Venture (MMV)
     

    Invited Speakers

    • Adam Renslo (UCSF): Mechanistic Studies of Trioxolane Action and a New Approach to Antimalarial Combination Therapy
    • Adegboyega K Oyelere (Georgia Institute of Technology)
    • Angela I Calderon (Harrison School of Pharmacy, Auburn University): Ultrafiltration and liquid chromatography based plasmodium falciparum thioredoxin reductase screening for  LIGANDS FROM PLANTS 
    • Gautam Chaudhuri (Meharry Medical College): Macrophage PAR1 and calpain 1 as drug targets against leishmaniasis
    • Harry de-Koning (University of Glasgow)
    • Hira Nakhasi (CBER/FDA)
    • Ian Gilbert (University of Dundee)
    • Jessica Kissinger (University of Georgia)
     
    • Karin  Seifert (London School of Hygiene & Tropical Medicine)
    • Karl Werbovetz (College of Pharmacy)
    • Kelly Chibale (University of Cape Town): Integration of ADME in Medicinal Chemistry Progression of Antiplasmodial Hits
    • Maria de Nazaré Correia Soeiro (Oswaldo Cruz Institute )
    • Minu Chaudhuri (Meharry Medical College): Mitochondrial protein translocase: as a novel drug target for African trypanosomiasis
    • Muhammad Ilias (University of Mississippi)
    • Sanjay A Desai (National Institute of Allergy and Infectious Diseases(NIAID))
     
    starting: ending: 15.12.2011 Location: , Category:

    Timeline

    Conference START 15.12.2011 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Occidental Grand Xcaret & Royal Club, Puerto Juarez Km 282 #307 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.